Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Brian Greffe

Concepts (238)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sarcoma, Ewing
3
2025
103
0.430
Why?
Kidney Neoplasms
4
2021
419
0.370
Why?
Hepatoblastoma
4
2022
52
0.360
Why?
Cisplatin
3
2025
347
0.260
Why?
Liver Neoplasms
4
2022
776
0.240
Why?
Bone Neoplasms
2
2025
272
0.230
Why?
Testicular Neoplasms
2
2017
108
0.220
Why?
Genetic Heterogeneity
1
2025
67
0.210
Why?
Rhabdomyosarcoma
2
2019
65
0.210
Why?
Clonal Evolution
1
2025
47
0.210
Why?
Wilms Tumor
2
2018
91
0.200
Why?
Granuloma, Plasma Cell
1
2003
12
0.200
Why?
Dexamethasone
1
2025
368
0.180
Why?
Hearing Loss
1
2025
177
0.180
Why?
Antineoplastic Agents
3
2025
2219
0.170
Why?
Single-Cell Analysis
1
2025
370
0.170
Why?
Pulmonary Blastoma
1
2021
8
0.170
Why?
RNA, Neoplasm
1
2021
76
0.160
Why?
Neoplasms
4
2025
2954
0.160
Why?
Eye Neoplasms
1
2021
31
0.160
Why?
Ribonuclease III
1
2021
44
0.160
Why?
Circulating Tumor DNA
1
2021
50
0.160
Why?
Biomarkers, Tumor
2
2025
1339
0.160
Why?
DEAD-box RNA Helicases
1
2021
90
0.160
Why?
Child
25
2025
22693
0.150
Why?
Protein C
2
1989
54
0.150
Why?
Adolescent
25
2025
22557
0.150
Why?
Child, Preschool
16
2025
11913
0.140
Why?
Neoplasms, Germ Cell and Embryonal
2
2016
76
0.130
Why?
Hodgkin Disease
2
2016
173
0.130
Why?
Carcinoma, Hepatocellular
1
2022
370
0.130
Why?
Neoplasm Proteins
1
2021
444
0.130
Why?
Cytodiagnosis
1
2017
31
0.120
Why?
Frozen Sections
1
2017
23
0.120
Why?
Seminoma
1
2017
20
0.120
Why?
Head and Neck Neoplasms
2
2021
563
0.120
Why?
Survivors
5
2016
526
0.120
Why?
Lung Diseases
1
2003
787
0.120
Why?
Central Nervous System Neoplasms
1
2019
177
0.120
Why?
Carcinoma, Squamous Cell
1
2021
628
0.110
Why?
Nuclear Proteins
1
2021
740
0.110
Why?
Health Planning
1
2015
46
0.110
Why?
Liver Transplantation
1
2022
751
0.110
Why?
Abdomen, Acute
1
1994
20
0.100
Why?
Osteosarcoma
2
2007
100
0.100
Why?
Prognosis
5
2025
4351
0.100
Why?
Male
29
2025
73396
0.100
Why?
Infant
13
2025
10114
0.100
Why?
Transition to Adult Care
1
2015
111
0.100
Why?
Heart Diseases
2
2016
343
0.100
Why?
Lymphoma, Large-Cell, Anaplastic
1
2013
23
0.100
Why?
Survival Rate
5
2019
2092
0.090
Why?
Ambulatory Care Facilities
1
2015
269
0.090
Why?
Sarcoma
1
2015
209
0.090
Why?
Humans
39
2025
146342
0.090
Why?
Gene Rearrangement
1
2013
156
0.090
Why?
Proto-Oncogene Proteins c-myc
1
2013
157
0.090
Why?
Bone Marrow Transplantation
3
2008
301
0.090
Why?
Denys-Drash Syndrome
1
2011
4
0.090
Why?
Embolectomy
1
2011
13
0.080
Why?
Receptor Protein-Tyrosine Kinases
1
2013
227
0.080
Why?
Female
27
2025
79499
0.080
Why?
Tumor Lysis Syndrome
1
2010
10
0.080
Why?
Lung Neoplasms
3
2021
2675
0.080
Why?
Mutation
1
2021
4093
0.070
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2010
1998
0.070
Why?
Pulmonary Embolism
1
2011
246
0.070
Why?
Lymphoma, B-Cell
1
2010
150
0.070
Why?
Risk Assessment
3
2015
3712
0.070
Why?
SEER Program
3
2016
233
0.070
Why?
Brain Neoplasms
4
1999
1325
0.070
Why?
Leiomyosarcoma
2
1998
30
0.060
Why?
Receptors, Erythropoietin
1
2007
21
0.060
Why?
Topotecan
1
2007
17
0.060
Why?
Fetal Blood
1
1989
325
0.060
Why?
Retrospective Studies
9
2022
17438
0.060
Why?
Infant, Very Low Birth Weight
1
2007
74
0.060
Why?
Young Adult
6
2025
14330
0.060
Why?
Translocation, Genetic
2
2021
127
0.060
Why?
Survival Analysis
3
2018
1378
0.060
Why?
Paraneoplastic Syndromes, Nervous System
1
2006
14
0.060
Why?
Carboplatin
1
2006
168
0.060
Why?
Oncogene Proteins, Fusion
2
2021
213
0.060
Why?
Leukemia
1
2008
246
0.060
Why?
Neuroblastoma
2
2006
177
0.060
Why?
Injection, Intratympanic
1
2025
2
0.060
Why?
Age Factors
3
2018
3347
0.060
Why?
Neoplasms, Radiation-Induced
1
2006
100
0.050
Why?
Pulmonary Artery
1
2011
1116
0.050
Why?
Follow-Up Studies
3
2025
5439
0.050
Why?
Gels
1
2025
86
0.050
Why?
Neoplasms, Second Primary
1
2006
103
0.050
Why?
Killer Cells, Natural
1
2008
481
0.050
Why?
Primary Health Care
1
2015
1776
0.050
Why?
Neoplastic Cells, Circulating
1
2025
81
0.050
Why?
Adult
14
2019
41087
0.050
Why?
Immunologic Factors
1
2006
244
0.050
Why?
Disease-Free Survival
2
2019
778
0.050
Why?
Abdominal Abscess
1
2003
28
0.050
Why?
Stem Cells
1
2008
613
0.050
Why?
Databases, Factual
3
2018
1493
0.050
Why?
Incidence
3
2007
2936
0.050
Why?
Pulmonary Veno-Occlusive Disease
1
2003
11
0.050
Why?
Spinal Neoplasms
1
2003
36
0.050
Why?
Combined Modality Therapy
3
2021
1271
0.050
Why?
Sequence Analysis, RNA
1
2025
441
0.050
Why?
Neoplasm Metastasis
2
2018
693
0.040
Why?
Recurrence
2
2003
1133
0.040
Why?
Proto-Oncogene Protein c-fli-1
1
2021
30
0.040
Why?
RNA-Binding Protein EWS
1
2021
31
0.040
Why?
Kidney Diseases, Cystic
1
2021
24
0.040
Why?
Antibodies, Monoclonal
2
2006
1512
0.040
Why?
Pneumothorax
1
2021
54
0.040
Why?
Tumor Microenvironment
1
2025
747
0.040
Why?
Infant, Newborn
4
2016
6460
0.040
Why?
Feasibility Studies
1
2025
1135
0.040
Why?
Thyroid Diseases
1
2000
45
0.040
Why?
Syndrome
1
2021
380
0.040
Why?
Germ-Line Mutation
1
2021
180
0.040
Why?
Radiotherapy
1
2021
209
0.040
Why?
Molecular Weight
2
1989
295
0.040
Why?
Gene Expression Regulation, Neoplastic
1
2025
1432
0.040
Why?
Smooth Muscle Tumor
1
1998
6
0.030
Why?
Sarcoma, Synovial
1
1998
20
0.030
Why?
Skull Neoplasms
1
1998
20
0.030
Why?
Gene Expression Profiling
1
2025
1792
0.030
Why?
Polymerase Chain Reaction
1
2021
1031
0.030
Why?
Vincristine
2
2010
148
0.030
Why?
Neoadjuvant Therapy
1
2021
475
0.030
Why?
Leiomyoma
1
1998
62
0.030
Why?
Neoplasm Staging
2
2017
1488
0.030
Why?
Fluorouracil
2
2010
231
0.030
Why?
Common Variable Immunodeficiency
1
1997
26
0.030
Why?
Intraoperative Period
1
2017
69
0.030
Why?
Polymyositis
1
1996
13
0.030
Why?
Epidemiological Monitoring
1
2016
70
0.030
Why?
Neoplasm Recurrence, Local
1
2022
1160
0.030
Why?
Neutropenia
1
1995
153
0.030
Why?
Organizational Innovation
1
2015
124
0.030
Why?
Pneumatosis Cystoides Intestinalis
1
1994
21
0.030
Why?
Interdisciplinary Communication
1
2015
200
0.030
Why?
Tomography, X-Ray Computed
2
2021
2786
0.030
Why?
Time Factors
3
2018
7109
0.030
Why?
Fever
1
1995
322
0.030
Why?
Laparotomy
1
1994
111
0.020
Why?
Graft vs Host Disease
1
1996
283
0.020
Why?
Klinefelter Syndrome
1
1995
68
0.020
Why?
Health Status
1
1999
827
0.020
Why?
Flow Cytometry
2
2008
1163
0.020
Why?
Immunohistochemistry
2
2013
1712
0.020
Why?
Program Development
1
2015
371
0.020
Why?
Emergencies
1
1994
177
0.020
Why?
Reproducibility of Results
1
2021
3416
0.020
Why?
Physical Examination
1
1994
237
0.020
Why?
Middle Aged
7
2017
36619
0.020
Why?
Transcription Factors
1
2021
1730
0.020
Why?
Immunocompromised Host
1
1994
201
0.020
Why?
Chronic Disease
2
2015
1827
0.020
Why?
Logistic Models
1
2018
2126
0.020
Why?
Aged
4
2022
26432
0.020
Why?
Analysis of Variance
1
2015
1298
0.020
Why?
Appendicitis
1
1994
151
0.020
Why?
In Situ Hybridization, Fluorescence
1
2013
334
0.020
Why?
Genetic Predisposition to Disease
1
2021
2488
0.020
Why?
Radiography
1
1994
861
0.020
Why?
Prevalence
1
2019
2861
0.020
Why?
United States
3
2017
16136
0.020
Why?
Disease Management
1
2015
651
0.020
Why?
Program Evaluation
1
2015
952
0.020
Why?
Disseminated Intravascular Coagulation
1
2010
34
0.020
Why?
Hyperuricemia
1
2010
47
0.020
Why?
Liver Function Tests
1
2010
103
0.020
Why?
Hyperkalemia
1
2010
35
0.020
Why?
Necrosis
1
2010
243
0.020
Why?
Practice Patterns, Physicians'
1
2017
1408
0.020
Why?
Maximum Tolerated Dose
1
2007
217
0.020
Why?
Herpesvirus 4, Human
2
1998
172
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2006
96
0.010
Why?
Urogenital Neoplasms
1
2006
5
0.010
Why?
Respiratory Insufficiency
1
2010
330
0.010
Why?
Cerebrospinal Fluid
1
2006
88
0.010
Why?
Behavior
1
2006
90
0.010
Why?
Granulocyte Colony-Stimulating Factor
1
2006
90
0.010
Why?
Thrombosis
1
1989
398
0.010
Why?
Rituximab
1
2006
208
0.010
Why?
Anti-Bacterial Agents
2
1995
1942
0.010
Why?
Gastrointestinal Neoplasms
1
2006
74
0.010
Why?
Colorado
1
2015
4595
0.010
Why?
Chemotherapy, Adjuvant
1
2006
429
0.010
Why?
Respiration, Artificial
1
2010
711
0.010
Why?
Hemorrhage
1
2010
825
0.010
Why?
Hematopoietic Stem Cell Transplantation
1
2010
704
0.010
Why?
Aged, 80 and over
1
2016
8391
0.010
Why?
RNA, Viral
2
1998
693
0.010
Why?
Survival
1
2003
38
0.010
Why?
Stereotaxic Techniques
1
2003
42
0.010
Why?
Thoracic Vertebrae
1
2003
90
0.010
Why?
Morbidity
1
2003
319
0.010
Why?
Transplantation, Autologous
1
2003
306
0.010
Why?
Motor Activity
1
2006
704
0.010
Why?
Immunotherapy
1
2006
671
0.010
Why?
B-Lymphocytes
1
2006
887
0.010
Why?
Hyperthyroidism
1
2000
22
0.010
Why?
Hypothyroidism
1
2000
68
0.010
Why?
Thyroid Nodule
1
2000
67
0.010
Why?
Sleep
1
2006
896
0.010
Why?
Sella Turcica
1
1998
17
0.010
Why?
Health Status Indicators
1
1999
167
0.010
Why?
Tumor Virus Infections
1
1998
51
0.010
Why?
Immunologic Deficiency Syndromes
1
1998
69
0.010
Why?
Fatal Outcome
1
1998
302
0.010
Why?
Herpesviridae Infections
1
1998
147
0.010
Why?
In Situ Hybridization
1
1997
317
0.010
Why?
Microscopy, Electron
1
1997
384
0.010
Why?
Acquired Immunodeficiency Syndrome
1
1998
238
0.010
Why?
Thyroid Neoplasms
1
2000
380
0.010
Why?
Prednisone
1
1996
229
0.010
Why?
Pineal Gland
1
1995
15
0.010
Why?
Leukocyte Count
1
1995
321
0.010
Why?
Anesthesia, Dental
1
1974
22
0.010
Why?
Tooth Extraction
1
1974
30
0.010
Why?
Magnetic Resonance Imaging
2
1998
3926
0.010
Why?
Anesthesia, General
1
1974
124
0.010
Why?
Anti-Inflammatory Agents
1
1996
474
0.010
Why?
Diagnosis, Differential
1
1996
1503
0.010
Why?
Quality of Life
1
2003
3200
0.000
Why?
Neutrophils
1
1995
1133
0.000
Why?
Cohort Studies
1
2000
6077
0.000
Why?
Treatment Outcome
1
2003
11821
0.000
Why?
Surveys and Questionnaires
1
1999
6073
0.000
Why?
Prospective Studies
1
1995
8123
0.000
Why?
Risk Factors
1
1995
10921
0.000
Why?
Oral Hemorrhage
1
1974
3
0.000
Why?
Tachycardia
1
1974
58
0.000
Why?
Angina Pectoris
1
1974
76
0.000
Why?
Postoperative Care
1
1974
301
0.000
Why?
Arrhythmias, Cardiac
1
1974
358
0.000
Why?
Anticoagulants
1
1974
746
0.000
Why?
Greffe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)